GHK-Cu-MAX-50
Copper Peptide|50 mg × 10 Vials
A research-grade copper peptide product supplied in a convenient 10-vial kit. Each vial contains 50 mg, with the complete kit containing 10 vials and 500 mg total peptide.
Supplied in a clearly identified vial format for controlled handling and research workflows, designed for qualified research and laboratory applications.
Product Highlights
About GHK-Cu
GHK-Cu, also known as Copper Tripeptide-1, is a naturally occurring copper-binding peptide that has been investigated in biochemical, cellular, and preclinical research.
Research surrounding GHK-Cu has examined its interaction with copper ions and its biological activity in various experimental models, including cellular signaling, extracellular matrix processes, tissue biology, and other mechanisms of biological interest.
Although GHK-Cu has been widely studied experimentally, research findings should not automatically be interpreted as evidence of established safety or efficacy for therapeutic use in humans.
GHK-Cu is best presented as an experimental research compound rather than an approved therapeutic product.
Product Specifications
| PRODUCT NAME | GHK-Cu-MAX-50 |
| COMPOUND | GHK-Cu |
| COMMON NAME | Copper Peptide |
| QUANTITY PER VIAL | 50 mg |
| NUMBER OF VIALS | 10 |
| TOTAL QUANTITY | 500 mg |
| PRODUCT TYPE | Research Peptide |
| PHYSICAL FORM | Lyophilized |
| INTENDED APPLICATION | Laboratory / Research Use |
| PACKAGING | 10-vial kit |
| BRAND | Maxtreme Pharma |
Research Applications
GHK-Cu has been investigated in a variety of preclinical and laboratory research settings because of its biological activity and copper-binding characteristics. Research areas may include:
These research areas describe experimental investigation and do not constitute approved medical indications or recommendations for human use.
Quality & Packaging
The GHK-Cu-MAX-50 kit contains 10 individually packaged vials, with 50 mg of labeled peptide per vial, providing a total labeled quantity of 500 mg.
The product packaging provides clear identification of the compound, strength, and total vial configuration, making the kit convenient for organized laboratory and research environments.
For professional research procurement, researchers should verify the applicable Certificate of Analysis (CoA), batch or lot information, purity specifications, identity testing, and storage requirements provided for the specific product batch.
Storage & Handling
Store and handle GHK-Cu-MAX-50 according to the manufacturer's batch-specific technical documentation and Certificate of Analysis.
Peptide stability can be affected by factors including temperature, moisture, light, formulation, and handling conditions. Researchers should therefore follow the manufacturer's documented storage and handling requirements rather than relying on generic recommendations.
Proper laboratory handling procedures should be followed when working with research peptides.
GHK-Cu is an experimental research compound and is not presented as a drug, dietary supplement, or approved treatment for any medical condition.
This product is intended for qualified researchers and laboratory applications in accordance with applicable laws, regulations, institutional requirements, and laboratory safety procedures.
No claim is made that GHK-Cu is safe or effective for the diagnosis, treatment, cure, or prevention of any disease or medical condition.
Not for human consumption or self-administration.
Frequently Asked Questions
GHK-Cu-MAX-50 is a research peptide product containing GHK-Cu (Copper Peptide). The kit contains 10 vials, with 50 mg of labeled peptide in each vial.
Each vial contains 50 mg of GHK-Cu.
The product package contains 10 vials.
The kit contains 500 mg total, calculated as 10 vials × 50 mg per vial.
GHK-Cu is commonly known as Copper Peptide or Copper Tripeptide-1.
GHK-Cu has been investigated in laboratory and preclinical research involving areas such as copper-binding activity, cellular signaling, extracellular matrix biology, and experimental tissue research. These research areas should not be interpreted as established medical applications.
The product should not be marketed as an approved human therapeutic. GHK-Cu is used and studied in various research contexts, but experimental findings do not establish approval, safety, or efficacy for treating medical conditions.
No. The product should be clearly presented as For Research Use Only and not for human consumption or self-administration, subject to the applicable laws and product requirements in the relevant jurisdiction.
For professional research procurement, customers should request the applicable Certificate of Analysis (CoA) and batch information. Depending on research requirements, documentation may include information relating to identity, purity, testing, and storage conditions.